Skip to main content
Top
Gepubliceerd in: Quality of Life Research 3/2013

01-04-2013

A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting

Auteurs: Waguih William IsHak, Konstantin Balayan, Catherine Bresee, Jared Matt Greenberg, Hala Fakhry, Scott Christensen, Mark Hyman Rapaport

Gepubliceerd in: Quality of Life Research | Uitgave 3/2013

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Major depressive disorder (MDD) negatively impacts different aspects of an individual’s life leading to grave impairments in quality of life (QOL). We performed a detailed analysis of the interaction between depressive symptom severity, functioning, and QOL in outpatients with MDD in order to better understand QOL impairments in MDD.

Methods

This cross-sectional study was conducted with 319 consecutive outpatients seeking treatment for DSM-IV-diagnosed MDD at an urban hospital-based outpatient clinic from 2005 to 2008 as part of the Cedars-Sinai Psychiatric Treatment Outcome Registry, a prospective cohort study of clinical, functioning, and patient-reported QOL outcomes in psychiatric disorders using a measurement-based care model. This model utilizes the following measures: (a) Depressive symptom severity: Quick Inventory of Depressive Symptomatology-Self Report (QIDS-SR); (b) Functioning measures: Global Assessment of Functioning (GAF), Sheehan Disability Scale (SDS), Work and Social Adjustment Scale, and the Endicott Work Productivity Scale; and (c) Quality of Life measure: Quality of Life, Enjoyment, and Satisfaction Questionnaire—Short Form (Q-LES-Q).

Results

QOL is significantly impaired in MDD, with a mean Q-LES-Q score for this study population of 39.8 % (SD = 16.9), whereas the community norm average is 78.3 %. Regression modeling suggested that depressive symptom severity, functioning/disability, and age all significantly contributed to QOL. QIDS-SR (measuring depressive symptom severity), GAF, and SDS (measuring functioning/disability) scores accounted for 48.1, 17.4, and 13.3 % (semi-partial correlation values) of the variance in Q-LES-Q, respectively.

Conclusions

Our results show that impairment of QOL increases in a monotonic fashion with depressive symptom severity; however, depression symptom severity only accounted for 48.1 % of the QOL variance in our patient population. Furthermore, QOL is uniquely associated with measures of Functioning. We believe these results demonstrate the need to utilize not only Symptom Severity scales, but also Functioning and Quality of Life measures in MDD assessment, treatment, and research.

Literatuur
  1. Constitution of the World Health Organization. (1946). American Journal of Public Health and the Nation’s Health, 36(11): 1315–1323.
  2. Bonicatto, S. C., Dew, M. A., Zaratiegui, R., Lorenzo, L., & Pecina, P. (2001). Adult outpatients with depression: Worse quality of life than in other chronic medical diseases in Argentina. Social Science and Medicine, 52(6), 911–919.PubMedView Article
  3. Papakostas, G. I., Petersen, T., Mahal, Y., Mischoulon, D., Nierenberg, A. A., & Fava, M. (2004). Quality of life assessments in major depressive disorder: A review of the literature. General Hospital Psychiatry, 26, 13–17.PubMedView Article
  4. Doraiswamy, P., Khan, Z. M., Donahue, J., & Richard, N. E. (2002). The spectrum of quality-of-life impairments in recurrent geriatric depression. Journal of Gerontology: Medical Sciences., 57A, M134–M137.View Article
  5. Saarijarvi, S., Salminen, J. K., Toikka, T., & Raitasalo, R. (2002). Health-related quality of life among patients with major depression. Nordic Journal of Psychiatry, 56(4), 261–264.PubMedView Article
  6. Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Warden, D., McKinney, W., Downing, M., et al. (2006). Factors associated with health-related quality of life among outpatients with major depressive disorder: A STAR*D report. Journal of Clinical Psychiatry, 67(2), 185–195.PubMedView Article
  7. Rapaport, M. H., Clary, C., Fayyad, R., & Endicott, J. (2005). Quality-of-life impairment in depressive and anxiety disorders. American Journal of Psychiatry, 162, 1171–1178.PubMedView Article
  8. Rush, A. J., & Trivedi, M. H. (1995). Treating depression to remission. Psychiatric Annals, 25, 704–709.
  9. Zimmerman, M., Mattia, J. I., & Posternak, M. A. (2002). Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? American Journal of Psychiatry, 159, 469–473.PubMedView Article
  10. Angst, J., Kupfer, D. J., & Rosenbaum, J. F. (1996). Recovery from depression: Risk or reality? Acta Psychiatrica Scandinavica, 93, 413–419.PubMedView Article
  11. Rapaport, M. H. (2009). Helping patients with depression achieve wellness. Journal of Clinical Psychiatry, 70(5), e11.PubMedView Article
  12. Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., et al. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(Suppl 20), 22–33; quiz 34–57.
  13. Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., et al. (2003). The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54(5), 585.View Article
  14. Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56(6), 893–897.PubMedView Article
  15. American Psychiatric Association. (1994). Global Assessment of Functioning in diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Publishing Inc.
  16. Sheehan, D. V. (1983). The anxiety disease. New York, NY: Scribner’s.
  17. Mundt, J. C., Marks, I. M., Shear, M. K., & Greist, J. H. (2002). The Work and Social Adjustment Scale: A simple measure of impairment in functioning. British Journal of Psychiatry, 180, 461–464.PubMedView Article
  18. Endicott, J., Nee, J., Harrison, W., & Blumenthal, R. (1993). Quality of life enjoyment and satisfaction questionnaire: A new measure. Psychopharmacology Bulletin, 29, 321–326.PubMed
  19. Schechter, D., Endicott, J., Nee, J. (2007). Quality of life of ‘normal’ controls: Association with lifetime history of mental illness. Psychiatry Research, 30 152(1):45–54.
  20. Beck, A. T., & Steer, R. A. (1990). Beck Anxiety Inventory manual. San Antonio, TX: Psychological Corporation.
  21. Fava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., et al. (2008). Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report. American Journal of Psychiatry, 165(3), 342–351.PubMedView Article
  22. Reed, C., Monz, B. U., Perahia, D. G., Gandhi, P., Bauer, M., Dantchev, N., et al. (2009). Quality of life outcomes among patients with depression after 6 months of starting treatment: Results from FINDER. Journal of Affective Disorders, 113(3), 296–302.PubMedView Article
  23. Fleck, M., Simon, G., & Herrman, H. (2005). Major Depression and its correlates in primary care settings in six countries. British Journal of Psychiatry, 186(1), 41–47.View Article
  24. Wisniewski, S. R., Rush, A. J., Bryan, C., Shelton, R., Trivedi, M. H., Marcus, S., et al. (2007). Comparison of quality of life measures in a depressed population. Journal of Nervous and Mental Disease, 195(3), 219–225.PubMedView Article
  25. Daly, E. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Gaynes, B. N., Warden, D., et al. (2010). Health-related quality of life in depression: A STAR*D report. Annals of Clinical Psychiatry, 22(1), 43–55.PubMed
  26. Piccinelli, M., & Wilkinson, G. (2000). Gender differences in depression. Critical review. British Journal of Psychiatry, 177, 486–492.PubMedView Article
  27. Fava, M., Alpert, J. E., Carmin, C. N., Wisniewski, S. R., Trivedi, M. H., Biggs, M. M., et al. (2004). Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychological Medicine, 34(7), 1299–1308.PubMedView Article
  28. Berlim, M. T., McGirr, A., & Fleck, M. P. (2008). Can sociodemographic and clinical variables predict the quality of life of outpatients with major depression? Psychiatry Research, 160(3), 364–371.PubMedView Article
  29. da Rocha, N. S., Power, M. J., Bushnell, D. M., & Fleck, M. P. (2009). Is there a measurement overlap between depressive symptoms and quality of life? Comprehensive Psychiatry, 50(6), 549–555.PubMedView Article
  30. Gureje, O., Kola, L., Afolabi, E., & Olley, B. O. (2008). Determinants of quality of life of elderly Nigerians: Results from the Ibadan study of ageing. African Journal of Medicine and Medical Sciences, 37(3), 239–247.PubMed
  31. Moore, M., Hofer, S., McGee, H., & Ring, L. (2005). Can the concept of depression and quality of life be integrated using a time perspective? Health and Quality of Life Outcomes, 5, 3–11.
  32. Ritsner, M. (2007). The distress/protection vulnerability model of quality of life impairment syndrome. In M. Ritsner & A. G. Awad (Eds.). Quality of life impairment in schizophrenia, mood, and anxiety disorders (pp. 3–19). The Netherlands: Springer.
  33. Bech, P. (1995). Quality-of-life measurements for patients taking which drugs? The clinical PCASEE perspective. Pharmacoeconomics, 7(2), 141–151.PubMedView Article
  34. Yen, C. F., Chen, C. C., Lee, Y., Tang, T. C., Ko, C. H., & Yen, J. Y. (2009). Association between quality of life and self-stigma, insight, and adverse effects of medication in patients with depressive disorders. Depression and Anxiety, 26(11), 1033–1039.PubMedView Article
  35. Skevington, S. M., Lotfy, M., O’Connell, K. A., & WHOQOL Group. (2004). The World Health Organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research, 13, 299–310.PubMedView Article
  36. Kessler, R. C., Zhao, S., Blazer, D. G., & Swartz, M. (1997). Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. Journal of Affective Disorders, 45, 19–30.PubMedView Article
  37. Maier, W., Gansicke, M., & Weiffenbach, O. (1997). The relationship between major and subthreshold variants of unipolar depression. Journal of Affective Disorders, 45, 41–51.PubMedView Article
  38. IsHak, W. W., Greenberg, J. M., Balayan, K., Kapitanski, N., Jeffrey, J., Fathy, H., et al. (2011). Quality of life: The ultimate outcome measure of interventions in major depressive disorder. Harvard Review of Psychiatry, 19, 229–239.PubMedView Article
Metagegevens
Titel
A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting
Auteurs
Waguih William IsHak
Konstantin Balayan
Catherine Bresee
Jared Matt Greenberg
Hala Fakhry
Scott Christensen
Mark Hyman Rapaport
Publicatiedatum
01-04-2013
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 3/2013
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-012-0187-6

Andere artikelen Uitgave 3/2013

Quality of Life Research 3/2013 Naar de uitgave